drugset / Trial / NCT00003192

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

NCT00003192 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of aminocamptothecin in treating patients with locally advanced, metastatic, or recurrent cancer of the stomach or esophagus.

Timeline

Start
1998-03
Primary completion
2002-02
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 9-aminocamptothecin Small molecule 25 ug/m2 Intravenous